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Abstract
Manyproteins associated with the phenotype microcephaly have been localized to the centrosome or linked to it functionally.
All the seven autosomal recessive primary microcephaly (MCPH) proteins localize at the centrosome. Microcephalic
osteodysplastic primordial dwarfism type II protein PCNT and Seckel syndrome (also characterized by severe microcephaly)
protein ATR are also centrosomal proteins. All of the above findings show the importance of centrosomal proteins as the key
players in neurogenesis and brain development. However, the exact mechanism as to how the loss-of-function of these
proteins leads to microcephaly remains to be elucidated. To gain insight into the function of the most commonly mutated
MCPH gene ASPM, we used the yeast two-hybrid technique to screen a human fetal brain cDNA library with an ASPM bait. The
analysis identified Angelman syndrome gene product UBE3A as an ASPM interactor. Like ASPM, UBE3A also localizes to the
centrosome. The identification of UBE3A as an ASPM interactor is not surprising as more than 80% of Angelman syndrome
patients have microcephaly. However, unlike in MCPH, microcephaly is postnatal in Angelman syndrome patients. Our results
show that UBE3A is a cell cycle regulated protein and its level peaks in mitosis. The shRNA knockdown of UBE3A in HEK293
cells led to many mitotic abnormalities including chromosome missegregation, abnormal cytokinesis and apoptosis. Thus our
studylinksAngelmansyndromeproteinUBE3AtoASPM,centrosomeandmitosisforthefirsttime.Wesuggestthatadefective
chromosome segregation mechanism is responsible for the development of microcephaly in Angelman syndrome.
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Introduction
Centrosomal proteins function in tango with cell cycle proteins
and the loss-of-function of these proteins leads to cell cycle
misregulation[1]. Mutationsinmanycentrosomal proteinencoding
genes have been linked to microcephaly, indicating the importance
of centrosomes in the expansion of neuronal progenitor cells.
Microcephaly is a neurological disorder characterized by a reduced
brain volume and head circumference (HC) which is three standard
deviations below the average HC for an individual’s age and sex.
Autosomal recessive primary microcephaly (MCPH; OMIM
251200) is a subtype defined by congenital microcephaly and
associated mental retardation (MR). It is genetically heterogeneous
with seven known loci and the genes for all seven loci have been
identified: MCPH1-MCPH1,M C P H 2 - WDR62,M C P H 3 - CDK5RAP2,
MCPH4-CEP152,M C P H 5 - ASPM,M C P H 6 - CENPJ, and MCPH7-
STIL [2,3,4,5,6,7,8].
The most common cause of MCPH is mutations in the ASPM
(abnormal spindle-like, microcephaly-associated protein) gene
[3,9,10,11,12]. ASPM is the human orthologue of the Drosophila
melanogaster asp (abnormal spindles) gene. It encodes for a 3,477
amino acids protein and is widely expressed in many human fetal
and adult organs including brain, kidney, muscle and lung [13].
Using RNAi knockdown approach, Fish and colleagues demon-
strated that the loss of Aspm in mouse neuroepithelium alters the
orientation of cleavage plane in the progenitor cells, resulting in an
increase in asymmetric divisions and reduction in the neuronal
progenitor pool [14].
Bioinformatic analysis has predicted the following domains and
motifs in ASPM: an N-terminal microtubule binding domain, two
calponin homology domains, 81 IQ (isoleucine-glutamine) repeat
motifs, and a C-terminal region with a conserved armadillo-like
repeat domain [12]. A recent C. elegans study demonstrated that the
IQ motifs in ASPM-1 associate with calmodulin to affect ASPM-1’s
centrosomal localization [15]. Apart from IQ motifs, the rest of the
domains remain to be characterized functionally. Interestingly, the
loss ofthe last149 aminoacidsfrom the C-terminalregionofASPM
is sufficient to cause MCPH [9], indicating that it is indispensable
forthefunctionofASPManddirectlyinvolvedinneurogenesis.The
purpose of this study was to investigate the novel protein
interactions mediated by the C-terminal region of ASPM.
Results
Yeast two-hybrid (Y2H) analysis with a C-terminal region
of ASPM
To find novel interacting partners for the C-terminal region
(CTR) of ASPM, we cloned this region corresponding to amino
PLoS ONE | www.plosone.org 1 May 2011 | Volume 6 | Issue 5 | e20397acids 3,276–3,477 in the Y2H DNA binding domain vector
pGBKT7 (Figure 1A). The clone (pGBKT7-CTR) was subse-
quently used as a bait to screen a human fetal brain cDNA library
cloned in the Y2H activation domain vector pACT2. The screen
identified eight transformants which were further tested for growth
and blue color on plates with quadruple dropout medium (SD/-
His/-Ade/-Leu/-Trp) and X-a-gal. DNA sequence analysis of the
pACT2 plasmid from one of the transformants showed that it
harbours a 714 bp long fragment of UBE3A (ubiquitin protein
ligase E3A) corresponding to amino acids 639–875. The 714 bp
fragment of UBE3A was recloned in pACT2 (pACT2-UBE3A)
and co-transformed with the bait pGBKT7-CTR in yeast cells.
The transformant was re-assessed by nutritional selection and X-
a-gal plate assay as described above. The growth of the
transformant and blue color suggested that ASPM interacts with
UBE3A (Figure 1B). The region of UBE3A from amino acids 639–
875 overlaps with the HECT domain (homologous to the E6AP
carboxyl terminus) of UBE3A which is known to be involved in
ubiquitination of its target proteins (Figure 1C).
ASPM interacts with UBE3A in vivo
To confirm the interaction of ASPM with UBE3A using co-
immunoprecipitation in vivo, we first raised a rabbit polyclonal
antibody against the N-terminal region of ASPM (Figure 1A), as a
commercial antibody was unavailable when we started this
experiment. The specificity of the ASPM antibody was verified
by Western blotting (Figure S1) and immunofluorescence
(Figure 2A and B). The raised anti-ASPM antibody recognized
the 56 kDa immunogen (Figure S1A). As expected Western blot
analysis with human fetal kidney lysate showed a 410 kDa band
corresponding to a full-length ASPM protein (Figure S1B). The
same result was obtained with a commercial ASPM antibody
when it became available (Figure S1B). Here after, we have used
the anti-ASPM antibody raised in our laboratory for all the
experiments.
Immunofluorescence staining of HEK293 cells with anti-ASPM
antibody showed immunoreactivity at the centrosome as reported
earlier [13] (Figure 2A). The specific staining of centrosomes by
anti-ASPM antibody was confirmed by its colocalization with c-
tubulin, a centrosomal marker (Figure 2A, upper panel). The
specificity of the anti-ASPM antibody was further confirmed by
absence of centrosomal staining with rabbit pre-immune serum
(Figure 2A, lower panel). As reported in the literature, the anti-
ASPM antibody was found to stain midbody during cytokinesis in
HEK293 cells [16] (Figure 2B, upper panel). ASPM localization
was also seen at MTOC (microtubule organizing center) in mitotic
Figure 1. Identification of interaction between ASPM and UBE3A by Y2H analysis. (A) Schematic representation of putative domains and
motifs in ASPM. A C–terminal region of ASPM, named CTR (amino acids 3,276–3,477) used as a bait in Y2H analysis is shown. An N-terminal region
(amino acids 544–1,059) encompassing the predicted microtubule binding domain and a part of calponin homology domain used for antibody
generation is also shown. (B) Y2H screening of transformants by nutritional selection and X-a-gal plate assay. Note growth and blue color for
transformants harboring pVA3+pTD1 (positive control) and pACT2-UBE3A+pGBKT7-CTR. As expected, no growth and blue color were observed for
transformants harboring pLam59+pTD1, pACT2+pGBKT7, pACT2+pGBKT7-CTR and pACT2-UBE3A+pGBKT7. (C) Schematic representation of UBE3A
protein. The ASPM interacting region of UBE3A (amino acids 639–875) is located within the HECT domain (amino acids 545 to 875). The numbers
represent amino acid positions.
doi:10.1371/journal.pone.0020397.g001
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panel). Further, a 410 kDa ASPM band was detected in lysates
from human fetal brain and four cell lines (viz., HEK293, A549,
HeLa and HepG2) by Western blotting (Figure 2C). In the same
panel of lysates, goat anti-UBE3A-sc-8926 antibody detected the
expected 100 kDa band (Figure 2C). The physical interaction
between ASPM and UBE3A was confirmed in vivo using human
fetal kidney lysate. Due to the limited availability of human fetal
brain tissue, we used the fetal kidney tissue for co-immunopre-
ciptation studies as it was readily available. Immunoprecipitation
using anti-ASPM antibody followed by immunoblot analysis using
anti-UBE3A-sc-8926 antibody detected a 100 kDa band corre-
sponding to the expected size of UBE3A (Figure 2D). Similarly,
immunoprecipitation with anti-UBE3A antibody pulled down
ASPM (Figure 2D). Pre-immune serum (PIS/IgG) and protein A/
G beads (P A/G) did not pull down either of the proteins
(Figure 2D).
UBE3A localizes to the centrosome throughout mitosis
An analysis of UBE3A immunofluorescence staining with anti-
UBE3A-sc-8926 antibody in HEK293 cells by confocal microsco-
py revealed that it stains the centrosome throughout the mitotic
progression from prophase to telophase and colocalizes with
ASPM (Figure 3A). Identical results were obtained in A549 cell
line (Figure 3B). In interphase cells, UBE3A staining observed at
the centrosome was weak (Figure 3A). A similar result was
obtained using a different anti-UBE3A antibody (anti-UBE3A-sc-
12380), confirming the centrosomal localization of UBE3A
(Figure 4). Henceforth, we have used the anti-UBE3A-sc-8926
antibody for all the experiments.
UBE3A is a cell cycle dependent protein and its
overexpression does not degrade ASPM
We investigated the role of UBE3A in cell cycle further by
studying its cell cycle dependence. For this, we synchronized
HEK293 cells at three different stages- G1/S boundary, M phase
and S phase. The cells were stained with propidium iodide (PI) for
DNA content and analyzed by Flow cytometry to check for the
efficiency of synchronization (Figure 5A). Western blot analysis of
synchronous cells revealed that UBE3A levels fluctuate across the
cell cycle phases (Figure 5B). UBE3A was found to be maximally
expressed in M phase (Figure 5B). Whereas a minimum expression
of UBE3A was seen in S phase (Figure 5B). We observed that the
expression level of ASPM in S phase corroborates with UBE3A
(Figure 5B). Taken together, above observations imply that
UBE3A is under cell cycle regulation and its high expression level
in mitosis may be playing an important function.
Figure 2. Localization of ASPM and interaction of ASPM with UBE3A in vivo. (A) Indirect immunofluorescence of HEK293 cells stained with
anti-c-tubulin and raised anti-ASPM antibodies. Upper panel: Note ASPM (red) colocalizes with the centrosomal marker c-tubulin (green). Lower
panel: Pre-immune serum (PIS/normal IgG) does not show any signal. Scale bar=2 mm. (B) Immunofluorescence images of HEK293 cells stained with
anti-a-tubulin and raised anti-ASPM antibodies. Upper panel: note ASPM localizes at midbody during cytokinesis (arrow heads). Lower panel: note
ASPM localizes at spindle poles during metaphase (arrow heads). Scale bar=2 mm. (C) Expression profile of ASPM and UBE3A by Western blot analysis
using lysates from human fetal brain, human fetal kidney, HEK293, A549, HeLa and HepG2. Anti-ASPM and anti-UBE3A (anti-UBE3A-sc-8926)
antibodies recognize 410 kDa and 100 kDa bands, respectively. Note the ubiquitous expression of both proteins. (D) Co-immunoprecipitation of
ASPM and UBE3A in human fetal kidney tissue. Upper panel: immunoprecipitation of ASPM co-precipitates UBE3A (100 kDa). Lower panel:
immunoprecipitation of UBE3A co-precipitates ASPM (410 kDa). Input lane represents tissue lysate used in pulldown. None of these proteins
coprecipitated with either normal IgG or PA/G beads. Abbreviations: IB, immunoblotting; and, IP, immunoprecipitation.
doi:10.1371/journal.pone.0020397.g002
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UBE3A, we overexpressed UBE3A in HEK293 cells by transient
transfection of the pCMV4-HA-UBE3A construct and the cell
lysates were examined for ASPM levels. ASPM levels were found to
be unaffected (Figure 5C), indicating that ASPM is not degraded by
a UBE3A-dependent proteasomal pathway or the degradation may
be under spatial-temporal control. Further, we wanted to check if
overexpressionofUBE3Aaffectsthe localizationoraccumulationof
ASPM at centrosomes. Immunofluorescence analysis of UBE3A
overexpressing HEK293 cells revealed that UBE3A does not affect
either the ASPM localization or its protein levels at the centrosome
(Figure 5D). The centrosomal localization of UBE3A was further
confirmed as HA-tagged UBE3A was found to be colocalized with
ASPM to the centrosome (Figure 5D).
UBE3A depleted cells show chromosome segregation
defects and abnormal spindles
To ascertain the functional significance of an increased level of
UBE3A in M phase (Figure 5B) and its interaction with ASPM,
Figure 3. UBE3A colocalizes with ASPM at the centrosome. (A) Indirect immunofluorescence of HEK293 cells at interphase and different
phases of mitosis stained with antibodies against ASPM and UBE3A (anti-UBE3A-sc-8926). Note colocalization of UBE3A with ASPM at the centrosome
throughout mitosis (arrowheads). Note weak centrosomal staining of UBE3A in an interphase cell (arrow). (B) Indirect immunofluorescence of A549
cells stained with antibodies against UBE3A (anti-UBE3A-sc-8926) and ASPM at metaphase and telophase. Note colocalization of UBE3A with ASPM at
the centrosome (arrowheads). Scale bar=2 mm.
doi:10.1371/journal.pone.0020397.g003
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shRNA (short hairpin RNA) construct and generated stable cell
lines. Western blot analysis of three stable clones (B, T and U)
showed more than 80% knockdown in UBE3A expression and
two clones (T and U) were further used in analysis (Figure 6A
and B). As a negative control, two (P and K) of three scrambled
clones were also used (Figure 6A and B). Immunofluorescence
analysis of UBE3A shRNA knockdown clones revealed a
reduced staining of UBE3A at the centrosome as compared to
scrambled clones (Figure 6C). No significant difference was
found in the protein level of ASPM in UBE3A depleted cells as
compared to scrambled cells (Figure 6D), suggesting that the
interaction of UBE3A with ASPM has no role in regulating the
protein level of ASPM.
Confocal microscopy analysis of UBE3A knockdown cells with
triple staining for ASPM (red), a-tubulin (green) and DNA (blue)
showed mitotic defects (Table 1). We examined the cells at
different stages of mitosis for defects in unsynchronized cultures of
two UBE3A knockdown clones (clone T, n=152 and clone U,
n=162) and two control scrambled shRNA clones (clone P,
n=153 and clone K, n=157). We scored the cells for the
following abnormalities: prometaphase/metaphase cells for mis-
aligned chromosomes and multipolarity (Figure 6E and F) and
anaphase/telophase cells for missegregation/lag of chromosomes
(Figure 7). ASPM remained at the centrosome in UB3EA depleted
cells indicating that its centrosomal localization is UBE3A
independent (Figures 6F and 7). The cells in prophase displayed
no abnormalities and a relatively low frequency of defects was
found in metaphase (Table 1). At anaphase/telophase stage,
defects were more evident as cells showed an increased frequency
of lagging chromosomes and missegregation (Figure 7; Table 1).
Chromosome missegregation/lag was observed in 38.71% and
Figure 4. Confirmation of colocalization of UBE3A with ASPM at the centrosome using a different UBE3A antibody. Indirect
immunofluorescence of HEK293 cells at interphase and different phases of mitosis stained with antibodies against ASPM and UBE3A (anti-UBE3A-sc-
12380). Note anti-UBE3A-sc-12380 antibody (arrowheads) also shows a centrosomal staining pattern as observed with anti-UBE3A-sc-8926 antibody.
Scale bar=2 mm.
doi:10.1371/journal.pone.0020397.g004
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respectively as compared to 10.17% in scrambled clone P and
8.16% in scrambled clone K cells (Table 1). Interestingly, we
observed that most of the UBE3A shRNA knockdown cells
displaying chromosome missegregation showed abnormal spindles
(Figure 7).
UBE3A knockdown leads to abnormal cytokinesis and
apoptosis
We next examined if chromosome missegregation/lag in
UBE3A depleted cells is leading to cytokinesis failure and
micronuclei formation. Cytokinesis failure is characterized by an
extended nuclear morphology reminiscent of missegregated
chromosomes and an elongated midbody [17]. We could notice
many of these phenotypes in UBE3A depleted cells (Figure 8A).
The scrambled clones P and K displayed normal cytokinesis
(Figure 6E). These defects appear when the lagging chromosomes
are pushed by the cleavage furrow into either one of the two
daughter cells, leading to micronuclei formation and abnormal
cytokinesis (Figure 8A). We were unable to score for cytokinesis
abnormalities due to low percentage of these cells. This may be
due to rescue of the abnormal phenotype or cell death.
Malfunctioning of chromosome segregation can generate aneu-
ploid cells and these cells are usually inviable. With this reasoning,
we examined the caspase-3 activation in cells to monitor apoptosis.
We noticed a significantly higher percentage of caspase-3 positive
cells in UBE3A depleted cells as compared to scrambled cells
(Figure 8B). For example, the percent of apoptotic cells in UBE3A
depleted clone U was 3-fold higher as compared to scrambled
clone K (Figure 8B).
Discussion
The C-terminal region of ASPM is a prerequisite for its
function, as its loss is enough to cause MCPH [9]. The precise
functional role of this indispensable region of ASPM and its
interactions with other proteins has been lacking. Given this
scenario, we screened a human fetal brain library with an ASPM
C-terminus bait and identified Angelman syndrome (AS) gene
product UBE3A as an interacting partner. This is the second
reported interaction of ASPM, apart from citron kinase [16].
Mutation in CITK is known to cause severe microcephaly in rats
and mice [18]. The identification of UBE3A as an ASPM
interactor is not unexpected as more than 80% of AS patients have
microcephaly [19]. However, unlike in MCPH where microceph-
aly is congenital, it develops postnatally in AS patients usually by
the age of two years [19]. Further, AS patients have other clinical
features (e.g., ataxia, a characteristic electroencephalogram,
happy- puppet-like gait and inappropriate laughter) that are not
present in MCPH patients. Therefore, the molecular mechanisms
involved in the development of microcephaly in AS could be
different than in MCPH [20,21]. It is interesting to note that
overall reduction in brain size (microcephaly) has been reported in
a mouse model of AS [22]. These studies underline the role of
UBE3A in determining brain size. Like ASPM, Ube3a is also
expressed in cerebral cortex [23]. Till date, studies indicate both
cytoplasmic and nuclear localization of UBE3A [23]. We have for
the first time demonstrated a centrosomal localization of UBE3A
(Figure 3–4). It is surprising that UBE3A’s centrosomal localiza-
tion has gone unnoticed so far. Therefore, our study opens a whole
new perspective on UBE3A function. The interaction of UBE3A
with ASPM and its centrosomal localization reveal its new
subcellular location and function in mitosis.
Although all the MCPH proteins localize at the centrosome,
intriguingly their localization is cell cycle dependent [4,6,7,13,
24,25]. For example, MCPH1, WDR62, CDK5RAP2, ASPM, and
CENPJ are all localized at the centrosome throughout the mitosis
[4,7,13,16,24]. However, only MCPH1, CDK5RAP2, ASPM, and
CENPJ are found at the centrosome in interphase cells [4,13,24].
Interestingly, STIL is associated with spindle poles only in
metaphase cells [25]. Three of the MCPH proteins- CDK5RAP2,
Figure 5. UBE3A is a cell cycle dependent protein and it fails to
degrade ASPM. (A) Flow cytometric analysis of cells to confirm
synchronization in different cell cycle phases. Note the cells in G1 phase
show a 2n peak, cells in M phase with a 4n peak and cells in S phase fall
in between 2n-4n peaks, suggesting cell cycle arrest at these phases.
UN: unsynchronized cells. (B) HEK293 cells synchronized at different cell
cycle phases were analyzed for UBE3A and ASPM expression by Western
blot analysis. Note the expression of UBE3A was found to peak in M
phase as compared to its levels in G1 and S phases. The level of ASPM
peaks during G1 and M phases. Erk1/2 was used a loading control. The
level of Erk1/2 is known to remain unaffected during different phases of
cell cycle. (C) Western blot analysis of lysates from HEK293 cells
transfected with an increasing concentration of the pCMV4-HA-UBE3A
construct. Note UBE3A overexpression fails to degrade ASPM.
Overexpression of UBE3A was determined by probing the blot with
anti-HA antibody. b-Actin was used as a loading control. (D)
Immunofluorescence analysis of HEK293 cells overexpressing the
pCMV4-HA-UBE3A construct. UBE3A and ASPM staining were examined
by anti-HA and anti-ASPM antibodies respectively. Note overexpression
of UBE3A does not alter ASPM localization or protein level (compare
ASPM signals in upper and lower panels). Also note colocalization of
UBE3A with ASPM at the centrosome (upper panel). Cells transfected
with the pCMV-HA vector were also stained with anti-HA antibody as a
control (lower panel).
doi:10.1371/journal.pone.0020397.g005
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cytokinesis [16]. The centrosomal localization of UBE3A was found
to be similar to WDR62, as it stains centrosomes throughout mitosis
but its centrosomal localization in interphase cells is not very
prominent (Figure 3A).
To investigate the role of mitosis-dependent accumulation of
UBE3A, we depleted its levels in HEK293 cells by shRNA
(Figure 6A and B). With the loss of protein, we suspected the
essential events that require UBE3A function to be affected. To
address this, we scored for mitotic abnormalities in UBE3A
depleted cells (Table 1). Our analysis identified a definitive role of
UBE3A in chromosome segregation. We found a 4- to 5- fold
increase in the frequency of anaphase/telophase cells with
missegregated chromosomes in UBE3A knockdown clones as
compared to scrambled cells (Table 1; Figure 7). And as a
reminiscent phenotype of chromosome missegregation, we ob-
served abnormal cytokinesis and the presence of micronuclei in
UBE3A knockdown cells (Figure 8A). A defective chromosome
segregation process generates aneuploid cells that are usually
inviable [26]. As anticipated, we observed a higher percentage of
apoptotic cells in UBE3A knockdown clones as compared to
control clones (Figure 8B). We hypothesize that if a similar
mechanism exists in the neuronal cells, the loss of UBE3A function
would cause increased cell death and a reduced neural progenitor
pool leading to microcephaly. It is important to note that the
present study is done in an embryonic kidney cell line and future
experiments need to be performed to prove that a similar
mechanism exists in neuronal progenitor cells. Interestingly, an
extensive apoptosis has been found in the neural folds of MCPH7
gene STIL null mice embryos [27].
Figure 6. Generation of stable UBE3A shRNA knockdown clones and analysis of mitotic stages. (A) HEK293 cells transfected with a HuSH
29mer shRNA construct against UBE3A and puromycin resistant clones (B, T and U) were examined for knockdown by Western blot analysis. As a
control, clones (C, P and K) transfected with scrambled shRNA were also generated. Note reduced expression of UBE3A in clones B, T and U as
compared to scrambled clones C, P and K. (B) Densitometric analysis of blot in panel A. UBE3A knockdown clones T and U showed approximately 80%
knockdown as compared to the scrambled clone P and K. Bars represent average values from densitometric analysis of the bands obtained in three
separate experiments. (C) Representative images of scrambled and UBE3A shRNA knockdown prometaphase cells showing UBE3A staining. Note a
reduced UBE3A signal (arrowheads) at the centrosome in an UBE3A shRNA knockdown cell as compared to a scrambled cell. c-tubulin was used for
centrosomal staining (arrows). (D) Western blot analysis of lysates from scrambled clones P and K, and UBE3A knockdown clones T and U with anti-
ASPM antibody. Note that the ASPM protein level remains unaffected in UBE3A knockdown clones as compared to scrambled clones. b-Actin was
used as a loading control. (E) Representative images of mitotic cells at different stages from scrambled clone P showing normal chromosome
alignment and mitotic spindles. Arrows point to ASPM staining and arrowhead marks the midbody. Scale=2 mm. (F) Cells from UBE3A knockdown
clone T showing misalignment of chromosomes and multipolarity at metaphase. Note an arrow points to misaligned chromosomes which lie outside
the spindle poles (upper panel). Note in two multipolar cells (lower panel), the different poles are marked with arrowheads for lower right cell and
marked with ‘‘*’’ for upper left cell. Scale=2 mm.
doi:10.1371/journal.pone.0020397.g006
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studies associated with microcephaly-related proteins. For example,
depletion of MCPH1 leads to lagging chromosomes and delayed
cytokinesis in U2OS (osteosarcoma) cells [28]. However, unlike in
UBE3A depleted cells, the lagging chromosomes in MCPH1
depleted cells are observed at metaphase and not at anaphase [28].
Inhibition of CDK5RAP2 expression by siRNA in HeLa cells also
leads to increased chromosome misalignment and lagging chromo-
somes along with reduced expression of different checkpoint
proteins like BUBR1 and MAD2 [29]. Moreover, Lizarraga et al.
have recently implicated a Cdk5rap2 mutation in Hertwig’s anemia
(an) mice [30]. They found an inherent predisposition to
chromosomal aneuploidy in Cdk5rap2 an/an primary cells. Chro-
mosome segregation defects have also been reported in asterless
(CEP152 Drosophila orthologue) mutants and Drosophila dSas-4
(CENPJ Drosophila orthologue) knockouts in spermatocytes during
male meiosis [31,32]. Furthermore, studies by Gonzalez et al. have
shown that mutations in Drosophila asp cause non-disjunction in
Figure 7. Chromosome segregation defects associated with abnormal spindles in UBE3A shRNA knockdown clones. Examples of cells
attempting to divide with missegregated (clone T, anaphase) and lagging chromosomes (clone U, telophase) (arrows). Also note cells with
chromosomes hanging at the equatorial plane (clone U, anaphase and clone T, telophase) (arrows). Note the cells have disorganized mitotic spindles
(all four panels) and bundling of microtubules at the central spindle (clone U, telophase) and at MTOC (clone T, anaphase). Scale=2 mm.
doi:10.1371/journal.pone.0020397.g007
Table 1. Quantitation of mitotic abnormalities in scrambled and UBE3A shRNA knockdown cells.
Scrambled clone P
(n=153)
Scrambled clone K
(n=157)
UBE3A shRNA clone T
(n=152)
UBE3A shRNA clone U
(n=162)
Prophase 0/9=0% 0/13=0% 0/13=0% 0/12=0%
Prometaphase/
Metaphase
Misaligned
chromosomes
4/85=4.71% 1/95=1.05% 7/77=9.09% 6/99=6.06%
Multipolarity 12/85=14.12% 12/95=12.63% 17/77=22. 08% 19/99=19.19%
Anaphase/
Telophase
Missegregation/Lag 6/59=10.17% 4/49=8.16% 24/62=38.71% 23/51=45.10%
Abbreviation: n=total number of mitotic cells observed.
doi:10.1371/journal.pone.0020397.t001
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knockdown of C.elegans aspm-1 causes defects in chromosome
segregation in meiosis I and II [15]. Examination of primary
fibroblasts from microcephalic osteodysplastic primordial dwarfism
type II patients has also provided evidence that the lack of PCNT
results in disorganized mitotic spindles, together with mosaic
variegated aneuploidy and premature sister chromatid separation
[34]. All the above studies show chromosome missegregation as a
common phenotype in cells with loss-of-function of MCPH and
other microcephaly-related proteins. It emphasizes the need for an
intact chromosome segregation machinery for the maintenance of
an optimal neural progenitor pool for normal brain development.
UBE3A belongs to the HECT-E3 ubiquitin ligase family of
enzymes [35]. Although the physiological functions of most
HECT-E3s are not well understood, it is becoming clear that
HECT-E3s play an important role in human diseases. HECT-E3s
Figure 8. Abnormal cytokinesis and apoptosis in UBE3A knockdown cells. (A) Note cells undergoing cytokinesis with elongated nuclear
morphology giving rise to abnormal number of nuclei. An extended midbody (arrowheads) and micronuclei (arrows) can be seen in all the panels.
ASPM was found to be diffusely present at the midbody. Scale=2 mm. (B) Quantitation of apoptosis by in vivo detection of caspase-3 activity. Note
UBE3A shRNA clones showed a significant increase in apoptotic cells as compared to scrambled clones. Cells were analyzed by flow cytometry using
FL-1 channel (10,000 cells were measured for each sample). Mean 6 SEM values for the samples is as follows: scrambled clone P=6.15060.2972,
scrambled clone K=4.92060.0986, UBE3AshRNA clone T=7.70060.2663, and UBE3AshRNA clone U=14.9960.2929. Data are representative of three
independent experiments. Unpaired Student’s t-test was used to determine the significance of difference between scrambled and UBE3A knockdown
clones.
doi:10.1371/journal.pone.0020397.g008
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tuberous sclerosis complex (HERCI) and cancer (Smurf2, UBE3A
and EDD), suggesting the functional spectrum of these proteins
[36]. Several lines of our data confirmed that ASPM interacts with
UBE3A, though a precise functional link between the two could
not be ascertained. Overexpresion of UBE3A in cells can mediate
degradation of its target proteins. For example, Yang et al. [37]
found that overexpression of UBE3A in HeLa cells leads to
degradation of its target protein trihydrophobin 1 (TH1). Shimoji
et al. [38] demonstrated that overexpression of UBE3A decreased
the level of annexin A1 protein in HEK 293T cells. In contrast, the
level of ASPM was found to be unaltered upon overexpression or
depletion of UBE3A in HEK293 cells in our study (Figures 5C and
6D). We suspect that the level of ASPM may be regulated by
UBE3A in cell-cycle dependent, temporal-, spatial- or tissue-
specific manner. For example, UBE3A interacts with HHR23A
(human homologue of the yeast DNA repair protein Rad23) to
degrade it specifically only in the S phase of cell cycle [39]. This
possibility needs to be explored in future as we have observed that
the levels of both ASPM and UBE3A decrease in S phase
(Figure 5B). The likelihood of a proteasomal-independent function
for the two proteins also exists.
The final number of neuronal progenitor cells determines the
brain size, which results from the balance between proliferation
and apoptosis [40]. The results from mouse Aspm siRNA study
have shown that Aspm increases the number of asymmetric
divisions in neuroepithelial cells leading to a reduced number of
cells and as a consequence a smaller brain size [14]. However, an
increased apoptotic mechanism seems to act in case of MCPH7
protein STIL to reduce the number of neuronal progenitors as
mentioned above [27]. In the present study, we also observed an
increased frequency of apoptotic cells in UBE3A knockdown
clones (Figure 8B). This suggests that microcephaly may be caused
by either a mechanism that affects cell fate determination and cell
proliferation (as in the case of ASPM) or an increase in apoptotic
signals in neural progenitor cells (as in the cases of STIL and
UBE3A).
To summarize, the data presented here showed that the
Angelman syndrome protein UBE3A interacts with primary
microcephaly protein ASPM and, like ASPM and other MCPH
proteins, localizes to centrosomes. We suggest that UBE3A is
required for proper chromosome segregation and its loss-of-
function leads to abnormal cytokinesis and apoptosis. It is possible
that a similar defective chromosomal segregation mechanism is
responsible for microcephaly in AS patients. We suggest that the
identification of the pathway where ASPM and UBE3A intersect
should now be the next most important goal.
Materials and Methods
Yeast two-hybrid (Y2H) analysis
For yeast two-hybrid analysis, we used the MATCHMAKER
GAL4 Two-Hybrid System 3 (Clontech Laboratories) and
Saccharomyces cerevesiae host strain AH109. The C-terminal region
of ASPM (CTR) from amino acids 3,276–3,477 was used as a bait
in yeast two-hybrid analysis (Figure 1A). To clone this region, total
RNA was isolated from human fetal brain using TRI RE-
AGENT
TM (Sigma-Aldrich) according to the manufacturer’s
instruction. First-strand cDNA was synthesized from total RNA
using the RevertAid
TM H Minus First Strand cDNA synthesis kit
(MBI Fermentas). RT-PCR primers used for the cloning of this
region in-frame with the GAL4-DNA binding domain in the
pGBKT7 vector are as follows: forward primer 59-atggatcc(Bam
HI)acctagaggtagttactagattgtctc-39 and reverse primer 59-atctg-
cag(Pst I)taaggaatgccaagcgtatccatcac-39. RT-PCR product was first
cloned in the TA cloning vector pTZ57R (MBI Fermentas).
Following digestion of the TA clone with Bam HI and Pst I, the
insert was eluted from the agarose gel and cloned in the pGBKT7
vector. The clone (pGBKT7-CTR) was sequenced on an
ABIprism A310-automated sequencer to verify the sequence.
The pGBKT7-CTR clone was subsequently used as a bait in
the yeast two-hybrid screening of a human fetal brain MATC-
MAKER cDNA library cloned in the activation domain vector
pACT2 (Clontech Laboratories). The transformants obtained
were screened for survival on plates with quadruple dropout
medium (SD/-His/-Ade/-Leu/-Trp). The surviving transformants
were further subjected to X-a-gal (5-Bromo-4-chloro-3-indolyl-a-
D-galactopyranoside) plate assay for the detection of yeast a-
galactosidase activity resulting from the expression of the MEL1
reporter gene. The MEL1 reporter gene is activated only when two
proteins interact with each other in a GAL4 based system and the
transformants appear blue in color. The plates were grown at
30uC in dark for 3 to 4 days and monitored for the appearance of
blue color. pTD1 and pVA3 plasmids co-transformed in the yeast
strain AH109 were used as a positive control for interaction. pVA3
encodes a fusion of the murine p53 protein (amino acids 72–390)
and the GAL4 DNA-BD (amino acids 1–147). pTD1 encodes a
fusion of the SV40 large T-antigen (amino acids 86–708) and the
GAL4-AD (amino acids 768–881). p53 is known to interact with
SV40 large T-antigen. A trasformant with pLAM59 and pTD1
was used as a negative control. pLAM59 encodes a fusion of the
DNA-BD (amino acids 1–147) with human lamin C (amino acids
66–230). Lamin C and SV40 large T-antigen do not interact with
each other. The surviving transformants were used for plasmid
DNA isolation as described in the instruction manual for the
MATCHMAKER GAL4 Two-Hybrid System 3. The insert in
pACT2 plasmid was amplified using the following vector specific
primers: forward 59-ctattcgatgatgaagataccccaccccaccaaacc-39, and
reverse 59-gtgaacttgcggggtttttcagtatctacga-39. These primers am-
plify a 178 bp product when the pACT2 vector is devoid of any
insert. The amplified insert was gel eluted and sequenced as
described above. The BLAST analysis was subsequently per-
formed to know the identity of the insert. The 714 bp fragment of
UBE3A was recloned in the pACT2 vector (pACT2-UBE3A) as
described above using cDNA from human fetal brain and
following primers: forward primer 59-tagagaattc(Eco RI)ccatggttgtc-
tacaggaagctaatgg-39, and reverse primer 59-tcaactcgag(Xho I)ttacag-
catgccaaatcctttggcata-39. The pACT2-UBE3A and pGBKT7-
CTR constructs were transformed again in yeast cells and tested
for growth on a plate with quadruple dropout medium and X-a-
gal with appropriate positive and negative controls.
Antibody generation, Western blot analysis and
co-immunoprecipitation
In order to generate an antibody against ASPM, a region from
amino acids 544–1,059 (MTB) was cloned in the bacterial
expression vector pET-33b(+) as described above using human
fetal brain cDNA as a template. Following expression and
purification of the bacterially expressed protein using a Ni
2+-
NTA column, it was injected in a rabbit. After four booster
dosages, antiserum was collected and affinity-purified on a Protein
A column (Bangalore Genei
TM). Pre-immune serum was also
collected from the rabbit prior to injection of the bacterially
expressed protein. Western hybridization was performed using a
standard method and HRP-conjugated secondary antibodies
(Bangalore Genei
TM), and an enhanced chemiluminescence
detection kit (Millipore). Primary antibodies used for Western
hybridization were as follows: raised anti-ASPM antibody (1:1500
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Biotechnology), goat anti-UBE3A antibody (1:750 dilution; sc-
8926, Santa Cruz Biotechnology), mouse anti-b-Actin (1:20,000
dilution; A 5441, Sigma-Aldrich), mouse anti-HA tag (1:5,000
dilution; H 9658, Sigma-Aldrich), and rabbit anti-Erk1/2 (1:1,000
dilution; Cell Signaling).
For co-immunoprecipitation of endogenous ASPM and
UBE3A, human fetal kidney tissue was lysed by homogenization
in an ice-cold cell lysis buffer (Sigma-Aldrich) supplemented with a
complete protease inhibitors mix (Sigma-Aldrich). The concentra-
tion of total protein was estimated by the Bradford assay. For
equilibration, protein-A/G agarose beads (Sigma-Aldrich) were
washed thrice in IP buffer containing detergent (20 mM HEPES
pH 7.5, 150 mM NaCl, 1 mM EDTA, 0.5% NP-40, 1 mM
sodium orthovanadate, 10 mM sodium fluoride, and 10% glycerol
supplemented with a complete protease inhibitors mix) and then in
IP buffer without detergent (20 mM HEPES pH 7.5, 150 mM
NaCl, 1 mM EDTA, 1 mM sodium orthovanadate, 10 mM
sodium fluoride, and 10% glycerol supplemented with a complete
protease inhibitors mix). One mg of the lysate was pre-cleared by
incubating it with normal IgG (pre-immune serum) and protein-
A/G agarose beads. Pre-cleared lysate was incubated with an
appropriate primary antibody for 3 hr at 4uC on a rotator. Thirty
ml of the protein-A/G agarose beads were added to the lysate and
primary antibody mix. The mix was incubated for 3 hr at 4uCo n
a rotator. Immune-complexes bound to protein-A/G agarose
beads were pelleted down and washed thrice with an ice-cold IP
buffer containing detergent and then with IP buffer without
detergent. Finally, the protein-A/G beads were resuspended in
20 ml of 1 x SDS-gel loading buffer, boiled for 10 min and spun
down by centrifugation at 12,000 rpm for 2 min at room
temperature. The supernatant containing immunoprecipitates
was then resolved on an appropriate percentage of SDS-PAGE
and the signals were detected using Western hybridization as
described above.
Tissue samples
Human fetal tissue samples were obtained from a spontaneous
abortus (18 weeks) which was frozen and stored at 280uC. Fetal
tissue samples were collected at the Kempegowda Institute of
Medical Sciences, Bangalore following approval from the Indian
Institute of Science’s ethics committee and written informed
consent from the mother.
Cell culture, transient transfection and cell cycle
synchronization
HEK293, HeLa, HepG2 and A549 cells were cultured in a
humidified 5% CO2 incubator at 37uC in DMEM supplemented
with 10% (vol/vol) fetal bovine serum and 1x antimycotic/
antibiotic mix (all from Sigma-Aldrich). Human cell lines were
procured from the National Repository for cell lines at National
Centre for Cell Sciences, Pune, India.
For overexpression of UBE3A, 2610
6 cells were transfected
with an increasing concentration of the pCMV4-HA-UBE3A
construct harbouring a full-length UBE3A gene (a kind gift from
Prof. Ikuo Shoji, Kobe University, Japan). Transfection was
carried out using Lipofectamine
TM 2000 (Invitrogen) according to
the manufacturer’s instruction. For immunofluorescence analysis
of HEK293 cells overexpressing HA-tagged UBE3A, two mgo f
pCMV4-HA-UBE3A was used for transfection.
To obtain cells synchronized at G1 phase, they were serum
deprived in culture media for 72 hr. Cells were treated with
300 nM nocodazole (Sigma-Aldrich) for 15 hr to obtain M phase
synchronized cells. To obtain cells synchronized in S phase,
double thymidine treatment was used. Briefly, cells were treated
with 2 mM thymidine (Sigma-Aldrich) for 18 hr. Cells were then
washed, replaced with fresh medium and grown for 9 hr prior to a
second treatment with 2 mM thymidine for 17 hr. DNA content
was measured by FACS analysis on a flow cytometer (BD Caliber)
and propidium iodide (PI) staining to confirm the cell cycle stage
and the efficiency of synchronization.
Immunofluorescence microscopy
HEK293 cells were grown on cover slips and allowed to adhere
and gain morphology overnight. Cells were fixed with chilled
methanol for 5 min. For a-tubulin staining, cells were treated with
MTSB buffer (80 mM PIPES pH 6.8, 1 mM MgCl2 and 4 mM
EGTA) for 1 min before fixing the cells. Cells were permeabilised
and blocked for nonspecific sites with 2% bovine serum albumin in
PBS plus 0.2% Triton-X-100. Cells were incubated with a primary
antibody at 4uC for 5 hr, followed by 2 hr of incubation with a
secondary antibody at room temperature. Primary antibodies used
were as follows: raised anti-ASPM antibody 1:15 dilution, goat
anti-UBE3A antibody 1:30 dilution (sc-8926; Santa Cruz Bioteh-
nology), goat anti-UBE3A antibody 1:10 dilution (sc-12380; Santa
Cruz Biotechnology), mouse anti-c-tubulin 1:15 dilution (sc-
17787; Santa Cruz Biotechnology), and mouse anti-a-tubulin
1:750 dilution (T 5168; Sigma-Aldrich). Staining was visualized
using an appropriate secondary antibody: mouse FITC (Sigma-
Aldrich), rabbit TRITC (Sigma-Aldrich), rabbit Cy5 (Invitrogen),
rabbit Cy2 (Molecular Probes), and goat Cy5 (Molecular Probes).
Cells were stained with either 1 ug/ml Hoechst 33258 or 1 mg/ml
propidium iodide (pseudo color blue) for 5 min. After washing,
coverslips were mounted on slides with an antifade solution
(Sigma-Aldrich) and photographed with a confocal Zeiss LSM 510
META microscope. The images were processed using LSM image
browser (http://www.zeiss.co.uk/).
shRNA knockdown
HEK293 cells were transfected with 1 mg of a shRNA construct
directed specifically against UBE3A (HuSH 29mer shRNA;
TR308522) purchased from OriGene Technologies. For transfec-
tion, Lipofectamine
TM 2000 (Invitrogen) was used according to the
manufacturer’s instruction. Scrambled shRNA construct was
transfected as a negative control. Puromycin resistant stable clones
were picked up, expanded in culture, aliquoted and frozen in
liquid nitrogen until use.
In vivo detection of apoptosis
Caspase-3 activity was determined to estimate apotosis by flow
cytometry (FACS Calibur, Becton Dickinson) using the Casp-
GLOW
TM Fluorescein Active Caspase-3 Staining kit (BioVision).
The kit provides sensitive detection of activated caspase-3 in living
cells. It utilizes the caspase-3 inhibitor, DEVD-FMK, conjugated
to FITC (FITC-DEVD-FMK) as a marker. For assay, 16106 cells
per well were seeded in a six-well plate, incubated for two days,
and processed according to the manufacturer’s protocol by adding
FITC-DEVD-FMK. Cells were washed twice in wash buffer and
resuspended in 300((l of wash buffer. Cells were then analyzed by
flow cytometry using FL-1 channel (10,000 cells were measured for
each sample).
Supporting Information
Figure S1 Validation of rabbit polyclonal anti-ASPM
antibody raised in the present study by Western blot
hybridization. (A) Bacterially expressed and purified recombi-
nant ASPM protein (MTB) probed with the raised anti-ASPM
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loaded in the gel is shown. Note the anti-ASPM antibody
recognizes the immunogen. (B) Western blot analysis of human
fetal kidney lysate with the raised anti-ASPM antibody and a
commercially available anti-ASPM antibody. Note both antibodies
recognize the predicted 410 kDa band.
(TIF)
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